Is Omnicell Stock a Good Investment?

Omnicell Investment Advice

OMCL

To provide specific investment advice or recommendations on Omnicell stock, we recommend investors consider the following general factors when evaluating Omnicell. This will help you to make an informed decision on whether to include Omnicell in one of your diversified portfolios:

Examine Omnicell's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Omnicell's leadership team and their track record. Good management can help Omnicell navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Technology space and any emerging trends that could impact Omnicell's business and its evolving consumer preferences.
Compare Omnicell's performance and market position to its competitors. Analyze how Omnicell is positioned in terms of product offerings, innovation, and market share.
Check if Omnicell pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Omnicell's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Omnicell stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Omnicell is a good investment.

Sell

Buy

Hold

Omnicell advice module can be used to check and cross-verify current recommendation provided by analysts analyzing the firm's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Omnicell is not overpriced, please check all Omnicell fundamentals, including its price to book, total debt, target price, as well as the relationship between the ebitda and cash flow from operations . Given that Omnicell has a price to earning of 64.95 X, we recommend you to check out Omnicell market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance	Weak	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Below Average	Details
Economic Sensitivity	Almost mirrors the market	Details
Investor Sentiment	Impartial	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Omnicell Stock

Researching Omnicell's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity recorded a loss per share of 0.39. The firm had not issued any dividends in recent years.

To determine if Omnicell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Omnicell's research are outlined below:

	Omnicell had very high historical volatility over the last 90 days
	The company reported the previous year's revenue of 1.15 B. Net Loss for the year was (20.37 M) with profit before overhead, payroll, taxes, and interest of 596.71 M.
	Over 98.0% of the company shares are owned by institutional investors
	Latest headline from news.google.com: The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research

Omnicell Quarterly Liabilities And Stockholders Equity

2.3 Billion

Omnicell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Omnicell. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Omnicell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	8th of February 2024 Upcoming Quarterly Report	View
	7th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	8th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Omnicell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Omnicell's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2011-05-02	2011-03-31	0.1	0.11	0.01	10
2010-10-27	2010-09-30	0.1	0.11	0.01	10
2010-04-26	2010-03-31	0.1	0.09	-0.01	10
2010-01-28	2009-12-31	0.1	0.11	0.01	10
2006-01-30	2005-12-31	0.07	0.08	0.01	14
2005-10-20	2005-09-30	0.04	0.05	0.01	25
2004-04-14	2004-03-31	0.07	0.08	0.01	14
2013-05-02	2013-03-31	0.19	0.21	0.02	10

Know Omnicell's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Omnicell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omnicell backward and forwards among themselves. Omnicell's institutional investor refers to the entity that pools money to purchase Omnicell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Lazard Asset Management Llc	2024-09-30	904.3 K
Bank Of New York Mellon Corp	2024-09-30	869.3 K
Morgan Stanley - Brokerage Accounts	2024-09-30	862.7 K
Federated Hermes Inc	2024-09-30	849.3 K
Cadian Capital Management Lp	2024-09-30	800 K
Sumitomo Mitsui Trust Group Inc	2024-09-30	750.5 K
Royal Bank Of Canada	2024-09-30	717.7 K
Mirae Asset Global Etfs Holdings Ltd.	2024-09-30	648.3 K
Charles Schwab Investment Management Inc	2024-09-30	595 K
Blackrock Inc	2024-06-30	8.2 M
Vanguard Group Inc	2024-09-30	5.5 M

Note, although Omnicell's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omnicell's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.08 B.

Market Cap

0.0 Omnicell's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.02)	(0.02)
Return On Capital Employed	(0.02)	(0.02)
Return On Assets	(0.01)	(0.01)
Return On Equity	(0.02)	(0.02)

The company has Profit Margin (PM) of (0.02) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.

Determining Omnicell's profitability involves analyzing its financial statements and using various financial metrics to determine if Omnicell is a good buy. For example, gross profit margin measures Omnicell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Omnicell's profitability and make more informed investment decisions.

Omnicell's Earnings Breakdown by Geography

Evaluate Omnicell's management efficiency

Return On Tangible Assets is expected to rise to -0.02 this year. Return On Capital Employed is expected to rise to -0.02 this year. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Return On Tangible Assets are projected to rise to (0.02). Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.

	Last Reported	Projected for Next Year
Book Value Per Share	26.30	27.61
Tangible Book Value Per Share	3.88	2.60
Enterprise Value Over EBITDA	30.44	22.21
Price Book Value Ratio	1.43	1.36
Enterprise Value Multiple	30.44	22.21
Price Fair Value	1.43	1.36

Omnicell showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.

Beta

0.815

Basic technical analysis of Omnicell Stock

As of the 23rd of December, Omnicell holds the Semi Deviation of 2.47, risk adjusted performance of 0.0336, and Coefficient Of Variation of 3139.72. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 44.5 per share. Given that Omnicell has jensen alpha of 0.116, we recommend you to check out Omnicell's recent market performance to make sure the company can sustain itself at a future point.

Omnicell's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omnicell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omnicell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omnicell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Randall Lipps over a week ago Disposition of 4202 shares by Randall Lipps of Omnicell at 46.01 subject to Rule 16b-3
		Parrish Mark W over a week ago Disposition of 12000 shares by Parrish Mark W of Omnicell at 47.3032 subject to Rule 16b-3
		Nchacha Etta over three weeks ago Disposition of 593 shares by Nchacha Etta of Omnicell at 45.67 subject to Rule 16b-3
		Nnamdi Njoku over a month ago Acquisition by Nnamdi Njoku of 53520 shares of Omnicell subject to Rule 16b-3
		Randall Lipps over three months ago Disposition of 2500 shares by Randall Lipps of Omnicell subject to Rule 16b-3
		Corey Manley over six months ago Disposition of 221 shares by Corey Manley of Omnicell at 27.91 subject to Rule 16b-3
		Joseph Spears over six months ago Disposition of 117 shares by Joseph Spears of Omnicell at 29.87 subject to Rule 16b-3
		Corey Manley over six months ago Acquisition by Corey Manley of 31965 shares of Omnicell subject to Rule 16b-3
		Corey Manley over six months ago Disposition of 222 shares by Corey Manley of Omnicell at 38.26 subject to Rule 16b-3
		Randall Lipps over six months ago Acquisition by Randall Lipps of 107251 shares of Omnicell subject to Rule 16b-3
		Joseph Spears over six months ago Disposition of 138 shares by Joseph Spears of Omnicell at 28.3 subject to Rule 16b-3
		Younger William H Jr over a year ago Exercise or conversion by Younger William H Jr of 9300 shares of Omnicell subject to Rule 16b-3

Omnicell's Outstanding Corporate Bonds

Omnicell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omnicell uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omnicell bonds can be classified according to their maturity, which is the date when Omnicell has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	MPLX LP 4875 Corp Bond US55336VAG59	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	ON SEMICONDUCTOR P Corp Bond US682189AQ81	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View

View All Omnicell Corporate Bonds

Understand Omnicell's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Omnicell's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0336
	Market Risk Adjusted Performance	0.1354
	Mean Deviation	2.32
	Semi Deviation	2.47
	Downside Deviation	2.67
	Coefficient Of Variation	3139.72
	Standard Deviation	4.74
	Variance	22.47
	Information Ratio	0.0251
	Jensen Alpha	0.116
	Total Risk Alpha	0.0082
	Sortino Ratio	0.0445
	Treynor Ratio	0.1254
	Maximum Drawdown	40.54
	Value At Risk	(3.86)
	Potential Upside	5.42
	Downside Variance	7.14
	Semi Variance	6.12
	Expected Short fall	(2.87)
	Skewness	4.79
	Kurtosis	32.71

	Risk Adjusted Performance	0.0336
	Market Risk Adjusted Performance	0.1354
	Mean Deviation	2.32
	Semi Deviation	2.47
	Downside Deviation	2.67
	Coefficient Of Variation	3139.72
	Standard Deviation	4.74
	Variance	22.47
	Information Ratio	0.0251
	Jensen Alpha	0.116
	Total Risk Alpha	0.0082
	Sortino Ratio	0.0445
	Treynor Ratio	0.1254
	Maximum Drawdown	40.54
	Value At Risk	(3.86)
	Potential Upside	5.42
	Downside Variance	7.14
	Semi Variance	6.12
	Expected Short fall	(2.87)
	Skewness	4.79
	Kurtosis	32.71

Consider Omnicell's intraday indicators

Omnicell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Omnicell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0429
	Daily Balance Of Power	(0.25)
	Rate Of Daily Change	0.99
	Day Median Price	44.47
	Day Typical Price	44.48
	Market Facilitation Index	1.95
	Price Action Indicator	(0.20)
	Period Momentum Indicator	(0.48)

Omnicell Corporate Filings

F4	17th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
8K	25th of November 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
10Q	8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
F3	11th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock	View Verify

Omnicell time-series forecasting models is one of many Omnicell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omnicell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Omnicell Stock media impact

Far too much social signal, news, headlines, and media speculation about Omnicell that are available to investors today. That information is available publicly through Omnicell media outlets and privately through word of mouth or via Omnicell internal channels. However, regardless of the origin, that massive amount of Omnicell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Omnicell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Omnicell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Omnicell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Omnicell alpha.

Omnicell Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Omnicell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Omnicell Corporate Management

Joseph Spears	Principal Chief Accounting Officer	Profile
Kathleen Nemeth	Senior Relations	Profile
Vicki MacDevitt	Chief Staff	Profile
Sara Dalmasso	Senior International	Profile
Minoo Mortazavi	Senior Operations	Profile
Corey Manley	Executive Officer	Profile

When determining whether Omnicell is a strong investment it is important to analyze Omnicell's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omnicell's future performance. For an informed investment choice regarding Omnicell Stock, refer to the following important reports: